Centennial, Colorado-based NetRegulus has scored a win near home, signing up Boulder-based Glucon, a medical devices firm developing a glucose monitoring device for the diabetes market. NetRegulus said that Glucon will use its software to manage its clinical trial schedule, and to manage the firm's clinical trials. NetRegulus provides compliance software for the life sciences arena. Glucon is backed by InnoMed, Giza Venture Capital, and others.
Top NewsMonday, February 13, 2006
NetRegulus Finds Customer In Glucon